- Home
- / Ventripoint Diagnostics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Ventripoint Diagnostics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-29
Market Capitalization
$17.6 M
2024-10-29
Revenue
$95 K
FY, 2024
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 60.0K | 81.0K | 36.0K | 68.0K | 49.0K | 95.0K | |
| Cost of goods sold | 34.0K | 44.0K | 10.0K | 10.0K | 7.0K | ||
| Gross profit | 32.0K | 132.0K | 260.0K | 58.0K | 42.0K | 95.0K | |
| Gross profit margin, % | 722.2% | 85.7% | 100.0% | ||||
| Operating expense total | 3.8M | 3.3M | 1.9M | 3.7M | 4.9M | 4.9M | 4.8M |
| Depreciation and amortization | 29.0K | 97.0K | 55.0K | 48.0K | 51.0K | 66.0K | 62.0K |
| EBITDA | (3.8M) | (3.1M) | (1.6M) | (3.7M) | (4.9M) | (4.9M) | (4.7M) |
| EBITDA margin, % | -4441.7% | -9928.6% | -4988.4% | ||||
| EBIT | (3.8M) | (3.2M) | (1.6M) | (3.9M) | (4.8M) | (4.9M) | (4.8M) |
| EBIT margin, % | -4555.6% | -9930.6% | -5045.3% | ||||
| Interest income | 50.0K | 25.0K | 77.0K | 9.0K | |||
| Interest expense | 11.0K | 214.0K | 220.0K | 18.0K | 35.0K | 66.0K | 187.0K |
| Pre tax profit | (2.1M) | (3.3M) | (1.9M) | (3.9M) | (4.9M) | (4.9M) | (5.0M) |
| Income tax expense | (83.0K) | ||||||
| Net Income | (2.1M) | (3.3M) | (1.9M) | (3.9M) | (4.9M) | (4.9M) | (4.9M) |